Clinical Benefits in Responders (N=31)
Disease-related anemia (baseline Hgb ? 11 g/dL)
- 73.3% (11/15) improved by ɮ g/dL to ᡃ g/dL
- Range 2.2 - 6.4 g/dL
- Not attributable to transfusions or erythropoietin
Performance Status (PS)
- 40.0% (8/20) improved PS
- 74.2% (23/31) maintained or improved PS
-